Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Journal article

Kaufmann M. et al, (2022), Nature Neuroscience

Structural and regulatory diversity shape HLA-C protein expression levels

Journal article

Kaur G. et al, (2017), Nature Communications, 8

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

Journal article

Dendrou CA. et al, (2016), Science Translational Medicine, 8

Natural killer cells and their receptors in multiple sclerosis

Journal article

Kaur G. et al, (2013), Brain, 136, 2657 - 2676

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Journal article

Gregory AP. et al, (2012), Nature, 488, 508 - 511

The role of Foxp3 in regulatory T cell differentiation and function

Journal article

Kaur G. et al, (2009), Current Immunology Reviews, 5, 89 - 101

A role of cellular prion protein in programming T‐cell cytokine responses in disease

Journal article

Ingram RJ. et al, (2009), The FASEB Journal, 23, 1672 - 1684

The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.

Journal article

Isaacs JD. et al, (2008), Immunology, 125, 313 - 319